Search

21963 results for: ‘%s’

  • Literary Leicester

    Join us for a free four-day Literary Leicester 2022 event including Adele Parks, Howard Jacobson and Monique Roffey.

  • Leading the management of change: Leadership 4

    Module code: MW4013 This module is facilitated through specialist lectures, leadership exercises and workshops, role-play, problem based scenarios, work-based learning and case loading.

  • Leading the management of change: Leadership 4

    Module code: MW4013 This module is facilitated through specialist lectures, leadership exercises and workshops, role-play, problem based scenarios, work-based learning and case loading.

  • Leading the management of change: Leadership 4

    Module code: MW4013 This module is facilitated through specialist lectures, leadership exercises and workshops, role-play, problem based scenarios, work-based learning and case loading.

  • Lauren Bartlett

    Lauren Bartlett is a strategic marketing and communications leader with over 15 years of experience growing brands, profits, and teams globally. Lauren currently leads marketing and communications in UK and Europe for New Zealand Trade & Enterprise.

  • Science 2: Mechanics

    Module code: FS0012 In this module you will learn how to describe and explain the motion of bodies subject to forces, including a focus on Newton’s Laws of motion and their application in various scenarios.

  • Available Vectors

    list of available vectors

  • Literary Leicester 2017 highlights

    Last month our annual Literary Leicester festival took place, featuring acclaimed literati guests, the dramatic arts and several school events.

  • Clare Anderson

    Information and contact details for Professor Clare Anderson FBA, Professor of History and Director, LIAS, at the University of Leicester.

  • Life-changing results of world first blood cancer drug trial revealed

    Researchers from the University and Leicester’s Hospitals have announced a breakthrough advance in the results of the world-first clinical trial with actual patients of a new drug to treat particular blood cancers.

Back to top
MENU